SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001516551-22-000040
Filing Date
2022-11-14
Accepted
2022-11-14 15:18:38
Documents
76
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q skye-20220930.htm   iXBRL 10-Q 1743304
2 EX-10.2 noticeofgrantofstockoption.htm EX-10.2 49426
3 EX-10.3 sharepurchaseagreementrela.htm EX-10.3 525147
4 EX-31.1 skye-20220930xex311.htm EX-31.1 10600
5 EX-31.2 skye-20220930xex312.htm EX-31.2 11129
6 EX-32.1 skye-20220930xex321.htm EX-32.1 5181
7 EX-32.2 skye-20220930xex322.htm EX-32.2 5321
  Complete submission text file 0001516551-22-000040.txt   10239289

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT skye-20220930.xsd EX-101.SCH 74607
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT skye-20220930_cal.xml EX-101.CAL 75259
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT skye-20220930_def.xml EX-101.DEF 423549
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT skye-20220930_lab.xml EX-101.LAB 758743
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT skye-20220930_pre.xml EX-101.PRE 559178
70 EXTRACTED XBRL INSTANCE DOCUMENT skye-20220930_htm.xml XML 1739779
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55136 | Film No.: 221384298
SIC: 2834 Pharmaceutical Preparations